Search research articles
Contact Us
Filters
Showing results (11-20 of 258) with videos related to
Page
of 26
Sort By:
Drug Metabolism and Pharmacokinetics
|
January 18, 2021
Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review
Shingo Oda, Tsuyoshi Yokoi
Drug Metabolism and Pharmacokinetics
|
September 6, 2005
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation
Miki Nakajima, Tsuyoshi Yokoi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
April 3, 2015
[Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms]
Shingo Oda, Tsuyoshi Yokoi
Drug Metabolism Reviews
|
March 17, 2007
Application of chimeric mice with humanized liver for predictive ADME
Miki Katoh, Tsuyoshi Yokoi
Annual Review of Pharmacology and Toxicology
|
November 30, 2012
microRNAs as mediators of drug toxicity
Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 16, 2002
Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10
Yuichiro Watanabe, Miki Nakajima, Tsuyoshi Yokoi
Toxicology
|
March 7, 2017
Establishment of a novel mouse model for pioglitazone-induced skeletal muscle injury
Sho Akai, Shingo Oda, Tsuyoshi Yokoi
Toxicology Letters
|
August 21, 2003
Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells
Miki Nakajima, Masashi Iwanari, Tsuyoshi Yokoi
Drug Metabolism Reviews
|
December 19, 2002
Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6
Miki Nakajima, Yukio Kuroiwa, Tsuyoshi Yokoi
Journal of Biochemistry
|
June 13, 2003
Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene
Yuki Tsuchiya, Miki Nakajima, Tsuyoshi Yokoi
Page
of 26
Search research articles
Search
Showing results (11-20 of 258) with videos related to
Sort By:
Page
of 26
Drug Metabolism and Pharmacokinetics
|
January 18, 2021
Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review
Shingo Oda, Tsuyoshi Yokoi
Drug Metabolism and Pharmacokinetics
|
September 6, 2005
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation
Miki Nakajima, Tsuyoshi Yokoi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
April 3, 2015
[Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms]
Shingo Oda, Tsuyoshi Yokoi
Drug Metabolism Reviews
|
March 17, 2007
Application of chimeric mice with humanized liver for predictive ADME
Miki Katoh, Tsuyoshi Yokoi
Annual Review of Pharmacology and Toxicology
|
November 30, 2012
microRNAs as mediators of drug toxicity
Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 16, 2002
Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10
Yuichiro Watanabe, Miki Nakajima, Tsuyoshi Yokoi
Toxicology
|
March 7, 2017
Establishment of a novel mouse model for pioglitazone-induced skeletal muscle injury
Sho Akai, Shingo Oda, Tsuyoshi Yokoi
Toxicology Letters
|
August 21, 2003
Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells
Miki Nakajima, Masashi Iwanari, Tsuyoshi Yokoi
Drug Metabolism Reviews
|
December 19, 2002
Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6
Miki Nakajima, Yukio Kuroiwa, Tsuyoshi Yokoi
Journal of Biochemistry
|
June 13, 2003
Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene
Yuki Tsuchiya, Miki Nakajima, Tsuyoshi Yokoi
Page
of 26